OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Lipidology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Mendelian randomization as a tool for causal inference in human nutrition and metabolism	46
Very long-chain saturated fatty acids and diabetes and cardiovascular disease	40
CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis	39
ANGPTL3 as therapeutic target	38
Lipids and peripheral neuropathy	29
Impact of ultra-processed food consumption on metabolic health	29
Update on apolipoprotein B	28
Management of familial hypercholesterolemia in pregnancy	25
Omega-3 fatty acids and cognitive function	25
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease	24
Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia	24
Depression and cardiovascular disease	23
Extracellular matrix: paving the way to the newest trends in atherosclerosis	23
The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk	23
Vascular stiffening and endothelial dysfunction in atherosclerosis	23
Lipids and brain inflammation in APOE4-associated dementia	23
Consensus and guidelines on lipoprotein(a) – seeing the forest through the trees	22
Small dense low-density lipoprotein particles: clinically relevant?	21
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives	21
Characteristics of plaque lipid-associated macrophages and their possible roles in the pathogenesis of atherosclerosis	20
Update on cerebrotendinous xanthomatosis	18
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease	18
Understanding the ins and outs of lipoprotein (a) metabolism	15
Familial combined hyperlipidemia is a polygenic trait	15
The iterative lipid impact on inflammation in atherosclerosis	14

Lipid effects of glucagon-like peptide 1 receptor analogs	14
HDL and persistent inflammation immunosuppression and catabolism syndrome	13
Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment	12
Dyslipidemia and aortic valve disease	12
Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications	11
New algorithms for treating homozygous familial hypercholesterolemia	11
Recent advances in ABCG5 and ABCG8 variants	11
The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case	11
Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart	11
Polygenic risk scores: how much do they add?	11
ANGPTL4: a new mode in the regulation of intravascular lipolysis	11
Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides	11
Angiopoietin-like proteins and postprandial partitioning of fatty acids	11
Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance	11
The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosis	11
Dietary factors and brain health	10
How should low-density lipoprotein cholesterol be calculated in 2022?	10
Therapeutic application of genome editing in dyslipidemia	9
Lipid effects of sodium-glucose cotransporter 2 inhibitors	9
Translating guidelines into practice via implementation science: an update in lipidology	9
Can we revive CETP-inhibitors for the prevention of cardiovascular disease?	9
The genetic counselor's role in management of patients with dyslipidemia	8
Proprotein convertase subtilisin/kexin type 9 inhibition after acute coronary syndrome or prior myocardial infarction	8
Recent lipoprotein(a) trials	8
Cross-species data integration to prioritize causal genes in lipid metabolism	7
Links between ceramides and cardiac function	7
Role of VLDL receptor in atherogenesis	7
New insights in statins affecting atheromatous plaque macrophages	7
Lipidomics in gestational diabetes mellitus	7
Metabolic regulation of macrophage proliferation and function in atherosclerosis	7
Fatty liver and cerebrovascular disease: plausible association and possible mechanisms	7
Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia	7
Evolving ANGPTL-based lipid-lowering strategies and beyond	7
Sphingomyelins and ceramides: possible biomarkers for dementia?	7